by Doug Bennett, University of Florida Molecular docking of sigma-2 receptor ligands that exhibit antiviral activity against SARS-CoV-2. (A), highly selective sigma-2 receptor agonist CM398 is shown as posed by AutoDock Vina to a model of the human sigma-2 receptor. (B), dual sigma-1 and sigma-2 receptor ligand AZ66 is shown as posed by molecular docking....
